Back to
BAMCO Inc.
ARWR
21 quarters
Position history for
BAMCO Inc.'s holdings in Arrowhead Pharmaceuticals, Inc.
No. BAMCO exited its ARWR (Arrowhead Pharmaceuticals) position in Q4 2023. Its Q3 2023 13F listed 156,619 shares worth $4.2M. BAMCO already held ARWR in its Q4 2018 13F, the earliest on record, and held it in 20 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$2.1M
Total Shares Change
-166,847
Quarter-by-Quarter History
Other major holders of ARWR: BlackRock, Inc., Vanguard Group Inc., Avoro Capital Advisors LLC